ChromoCure, Inc. (KKUR) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Specialties Branche. Der Hauptsitz des Unternehmens ist in Reno, United States.
KKUR hat IPO-Datum 2005-04-27, 4 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $8.2K.
ChromoCure, Inc. develops and provides proprietary cancer detection systems. The company offers Chromosomal Scanner Series 200, a cancer detection system to measure the genomic characteristic found in 100% of all cancers and never found in normal cells. It also applies its science and technology to non-toxic and non-invasive approaches to cancer therapy and cure research. The company was formerly known as Cyberhand Technologies International, Inc. and changed its name to ChromoCure, Inc. in June 2009. ChromoCure, Inc. was incorporated in 2001 and is based in Reno, Nevada.
